Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

CONTRIBUTING WRITER

Deepak Balak, MD, MSc
Erasmus MC, Department of Dermatology
Utrecht, Netherlands

Dr. Balak works as a dermatologist at the Department of Dermatology and Allergology of the University Medical Center Utrecht in Utrecht, the Netherlands, where he combines patient care with teaching responsibilities and research. His clinical interests are centered on the impact and management of inflammatory and autoimmune diseases. His scientific interests include translational medicine, clinical drug development, and evaluation in the field of chronic immune-mediated inflammatory skin diseases, such as psoriasis. As a 2019 Fellow, he will study with Dr. Alice Gottlieb at the Mount Sinai Hospital in New York, New York and attend the European Academy of Dermatology and Venereology Congress.

Last Updated: Nov 20, 2019

Latest news

May 28, 2020
Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when confronted with a severe threat to health, like the worldwide spread of the SARS-CoV-2 virus.
May 27, 2020
US-based rheumatologist and IPC Councilor Arthur Kavanaugh, MD, discusses his plans to continue offering telemedicine appointments to patients after the pandemic. "Telemedicine is a new skill set that [we] providers need to learn," says Dr. Kavanaugh in this week's Stories from the Field video.
May 26, 2020
May 20, 2020
Due to COVID-19 restrictions, patients in Egypt with severe psoriasis are not getting timely access to biologic treatment. IPC Board Member Mahira Hamdy El Sayed, MSc, MD, discusses the potential fallout for Egyptians with psoriasis, post-COVID-19.
  More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK